loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 209716 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Amneal Pharmaceuticals

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 AMNEAL PHARMS NY (1)

    filter

    01 CAPSULE, DELAYED RELEASE;ORAL (1)

    filter

    01 OTC (1)

    filter

    01 ESOMEPRAZOLE MAGNESIUM (1)

    filter

    01 No (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ESOMEPRAZOLE MAGNESIUM

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE, DELAYED R...
    EQ 20MG BASE
    2019-06-05
    209716
    ESOMEPRAZOLE MAGNE...
    OTC
    No
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 209716

    Looking for FDA Orange Book APPLICATION 209716 1

    19

    Amneal Pharmaceuticals, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is ESOMEPRAZOLE MAGNESIUM, with a corresponding application number 209716.

    Regulatory Information OTC

    With a dosage strength EQ 20MG BASE

    Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

    Reference Listed Drug No

    Approved since 2019-06-05

    Post Enquiry
    POST ENQUIRY